CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 136 filers reported holding CYTOKINETICS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $289,000 | -46.1% | 23,884 | -42.8% | 0.01% | -50.0% |
| Q1 2017 | $536,000 | +102.3% | 41,748 | +91.5% | 0.03% | +23.8% |
| Q4 2016 | $265,000 | +231.2% | 21,800 | +83.4% | 0.02% | +425.0% |
| Q2 2015 | $80,000 | -25.9% | 11,888 | -25.3% | 0.00% | -42.9% |
| Q1 2015 | $108,000 | -31.6% | 15,912 | -4.2% | 0.01% | -75.0% |
| Q1 2014 | $158,000 | +11.3% | 16,615 | +35.6% | 0.03% | +33.3% |
| Q2 2013 | $142,000 | – | 12,249 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |